Status:

COMPLETED

Determinants of Type 2 Diabetes Risk in Middle-aged Black South African Men and Women

Lead Sponsor:

University of Witwatersrand, South Africa

Collaborating Sponsors:

Medical Research Council, South Africa

GlaxoSmithKline

Conditions:

Diabetes Mellitus, Type 2

Insulin Resistance

Eligibility:

All Genders

35-65 years

Brief Summary

There is little known about menopause in African women, whose phenotype differs to Caucasian women, and no data is available on middle-aged black South African men. Accordingly, the study aims to exam...

Detailed Description

The study will be performed in two parts: Part 1 - Using a longitudinal design, a sample of 500 black women at different stages of the menopausal transition, and 500 middle-aged men living in Soweto ...

Eligibility Criteria

Inclusion

  • Part 1:
  • Women on whom baseline data was collected between 2011 and 2014 as part of the Study of Women Entering and in Endocrine Transition.
  • Men on whom baseline data was collected in 2014 as part of a larger African genomics study (www.h3Africa.org).
  • Part 2: A sub-sample of women from Part 1 of the study:
  • Pre-menopausal women age-matched within the age range 35-45 years;
  • Post-menopausal women age-matched within the age range 55-65 years;
  • All women: BMI 25-40 kg/m2

Exclusion

  • Part 1:
  • \- Failed to consent to participate in the study.
  • Part 2:
  • Diabetes, thyroid dysfunction, inflammatory, hepatic and renal diseases;
  • Use of hormone replacement therapy; hormonal contraceptives, oral cortisone, anti-inflammatory drugs or antiretroviral therapy;
  • Peri-menopausal;
  • Currently pregnant or lactating;
  • Tobacco use.

Key Trial Info

Start Date :

January 23 2017

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 31 2018

Estimated Enrollment :

1025 Patients enrolled

Trial Details

Trial ID

NCT03408678

Start Date

January 23 2017

End Date

July 31 2018

Last Update

June 14 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

SAMRC/WITS Developmental Pathways of Health Research Unit, University of Witwatersrand

Johannesburg, Gauteng, South Africa, 2013